Herman Perroud | Medicine and Dentistry | Best Researcher Award

Posted on by Invention Awards

Dr. Herman Perroud | Medicine and Dentistry | Best Researcher Award

Medical Oncology of Sanatorio de la mujer, Argentina

Dr. Herman Perroud is a distinguished MEDICAL ONCOLOGIST affiliated with SANATORIO DE LA MUJER, focusing on innovative research in BREAST CANCER and LUNG CANCER. His career is marked by leadership in the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and oversight of numerous clinical trials. With memberships in ASCO and ESMO, he contributes extensively to oncological advancements. Dr. Perroud’s contributions include publications in prominent journals, exploring new strategies like LOW DOSE CHEMOHERAPY for BREAST CANCER treatment. Recognized internationally for his scientific innovations, he continues to shape the field of oncology with dedication and expertise. 🌟🔬

Professional Profile:

 

Education🎓

Dr. Herman Perroud is a dedicated MEDICAL ONCOLOGIST at SANATORIO DE LA MUJER, focusing on BREAST CANCER and LUNG CANCER research. His academic endeavors include spearheading the EARLY DETECTION PROGRAM OF LUNG CANCER in ROSARIO ARGENTINA and contributing to clinical trials.

 

Professional Experience 📚

 

Dr. Herman Perroud, a distinguished Medical Oncologist affiliated with Sanatorio de la Mujer, brings extensive expertise in oncology and clinical research. With a robust career spanning years of dedicated service, he has contributed significantly to advancing cancer treatment methodologies, particularly in breast and lung cancers. Dr. Perroud leads multiple clinical trials, including an innovative Early Detection Program for Lung Cancer in Rosario, Argentina. His professional journey includes collaborations with international bodies like ASCO and ESMO, underscoring his commitment to global oncological advancements. Dr. Perroud’s impactful research, published in prestigious journals, focuses on early cancer detection and novel chemotherapy approaches for breast cancer treatment.

Research Interest 🔍

Dr. Herman Perroud’s research interests 🧬🔬 revolve around pioneering advancements in oncology, particularly focusing on breast and lung cancers. He is committed to exploring innovative methods for early cancer detection and refining therapeutic approaches, including low-dose chemotherapy. Dr. Perroud’s research aims to deepen the understanding of tumor biology and treatment modalities through rigorous clinical trials and collaborative studies. His work also encompasses investigating personalized medicine strategies and novel therapies to enhance treatment effectiveness and patient care in oncology.

Award and Honor🏆

Dr. Herman Perroud has received prestigious awards and honors in recognition of his contributions to medical oncology and research. His accolades underscore his dedication to advancing treatments for breast and lung cancers through innovative approaches. These awards highlight his significant impact on early detection methods for lung cancer in Rosario, Argentina, and his pioneering work in low-dose chemotherapy for breast cancer treatment. Dr. Perroud’s achievements are a testament to his leadership in the field, enhancing patient care and advancing scientific knowledge in oncology. 🏆🌟

Research Skills🌟

Dr. Herman Perroud is highly skilled in conducting cutting-edge research in the field of medical oncology, particularly focusing on breast cancer and lung cancer. His research skills encompass a wide range of methodologies, including clinical trials management and the implementation of innovative early detection programs. He demonstrates proficiency in data analysis, experimental design, and the application of advanced medical technologies to improve cancer diagnosis and treatment outcomes. Dr. Perroud’s contributions to the field reflect his deep commitment to advancing oncological research and translating scientific findings into impactful clinical practices, thereby significantly benefiting patients and the medical community alike.

Achievements🏅

  • Spearheaded the Early Detection Program of Lung Cancer in Rosario, Argentina.
  • Managed multiple clinical trials focusing on innovative treatments for breast cancer and lung cancer.
  • Published extensively in reputable journals on advancements in early cancer detection and low-dose chemotherapy.
  • Received international recognition and awards for contributions to oncological research.
  • Active member of prestigious organizations such as ASCO (American Society of Clinical Oncology) and ESMO (European Society for Medical Oncology).
  • Established collaborations with prominent researchers and institutions globally.
  • Contributed significantly to the development of new methodologies in cancer research and treatment.
  • Recognized for leadership in integrating research findings into clinical practice to enhance patient care and outcomes.

Publications🏅

  • Book Chapter
    • Title: Protective effect of Vitamin A on male lung cancer
    • Authors: Dagatti, M.S., Compagnucci, A.B., Perroud, H.A., Pezzotto, S.M.
    • Book: Vitamin A: Nutrition, Side Effects and Supplements, 2021, pp. 193–210
  • Review Article
    • Title: Achievements and challenges in the use of metronomics for the treatment of breast cancer
    • Authors: Scharovsky, O.G., Rico, M.J., Mainetti, L.E., Perroud, H.A., Rozados, V.R.
    • Journal: Biochemical Pharmacology, 2020, 175, 113909
  • Article
    • Title: Correlation between predictors of coledocolithasis and findings of endoscopic retrograde cholangiopancreatography. From guidelines to practice | Correlación entre predictores de litiasis coledociana y los hallazgos en la colangiopancreatografía retrógrada endoscópica. De las guías a la práctica
    • Authors: Ripari, G., Wulfson, A., Guerrina, C., Perroud, H.
    • Journal: Acta Gastroenterologica Latinoamericana, 2017, 47(4), pp. 269–276
  • Article
    • Title: Putative Biomarkers of Response to Treatment in Breast Cancer Patients: A Pilot Assay
    • Authors: Rico, M.J., Perroud, H.A., Herrera, C., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2017, 35(6), pp. 377–385
  • Article
    • Title: The association between osteoporotic hip fractures and actinic lesions as a biomarker for cumulative sun exposure in older people—a retrospective case–control study in Argentina
    • Authors: Perroud, H.A., Dagatti, M.S., Amigot, B., Masoni, A.M., Pezzotto, S.M.
    • Journal: Journal of Bone and Mineral Metabolism, 2017, 35(3), pp. 324–329
  • Article
    • Title: Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Scharovsky, O.G., Rozados, V.R., Alasino, C.M.
    • Journal: ecancermedicalscience, 2017, 11, 723
  • Article
    • Title: A nested case-control study on dietary fat consumption and the risk for gallstone disease
    • Authors: Bertola Compagnucci, A., Perroud, H.A., Batallés, S.M., Berli, D., Pezzotto, S.M.
    • Journal: Journal of Human Nutrition and Dietetics, 2016, 29(3), pp. 338–344
  • Article
    • Title: Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Future Oncology, 2016, 12(10), pp. 1233–1242
  • Article
    • Title: Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: Clinical outcomes and biomarkers of response
    • Authors: Perroud, H.A., Alasino, C.M., Rico, M.J., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Chemotherapy and Pharmacology, 2016, 77(2), pp. 365–374
  • Article
    • Title: Comparative effectiveness of two metronomic chemotherapy schedules-our experience in the preclinical field
    • Authors: Rico, M.J., Perroud, H.A., Mainetti, L.E., Rozados, V.R., Scharovsky, O.G.
    • Journal: Cancer Investigation, 2014, 32(3), pp. 92–98

John T McDevitt | Dentistry | Best Researcher Award

Posted on by Invention Awards

Prof. John T McDevitt | Dentistry | Best Researcher Award

 Professor of New York University, United States

🌟 Professor John T. McDevitt is a distinguished figure in biomaterials and ‘smart diagnostic‘ technologies at NYU College of Dentistry. As a visionary leader and founder of multiple diagnostic firms like OraLiva, he pioneers innovations for early disease detection. His extensive research, comprising 219+ publications and 145+ patents, reflects his profound impact on healthcare. Recognized with accolades such as the AACC Wallace H. Coulter Lectureship Award and the Presidential Young Investigator Award, Dr. McDevitt’s work integrates AI-linked sensors for diseases like oral cancer and COVID-19, securing over $47M in NIH funding. His contributions epitomize excellence in translating bioscience into transformative clinical solutions. 🏥

Professional Profile:

Education🎓

🎓 Professor John T. McDevitt pursued his academic journey with zeal, earning a B.S. in Chemistry/Sensors Devices from California Polytechnic State University in 1982. He continued his quest for knowledge at Stanford University, where he obtained his Ph.D. in Physical/Materials Chemistry in 1987. Following this, he conducted postdoctoral research in Analytical/Materials Chemistry at the University of North Carolina from 1987 to 1989. These formative years laid the foundation for his illustrious career in biomaterials and bioengineering, shaping his expertise in developing groundbreaking ‘smart diagnostic‘ technologies that advance healthcare. 📚

Professional Experience 📚

🌟 Professor John T. McDevitt brings over three decades of distinguished professional experience to his role. Currently serving as a Full Professor in the Division of Biomaterials at New York University College of Dentistry, he is also affiliated with the Bioengineering Institute and the Department of Chemical and Biomolecular Engineering at the Tandon School of Engineering. Previously, he held notable positions such as Chair of the Department of Biomaterials at NYU and the Brown-Weiss Professor of Bioengineering and Chemistry at Rice University. His leadership extends to directing multiple research consortia and clinical studies, driving innovations in smart diagnostic technologies for early disease detection and management. 🏆

Research Interest 🔍

🔬 Professor John T. McDevitt is deeply engaged in pioneering research at the intersection of biomaterials, bioengineering, and chemical engineering. His research endeavors focus on developing advanced ‘smart diagnostic‘ technologies aimed at revolutionizing healthcare delivery. His primary interests lie in creating miniaturized sensor ensembles and lab-on-a-chip systems for rapid, accurate disease diagnosis at the point of care. With a strong emphasis on integrating artificial intelligence with biomedical devices, his work spans critical areas such as oral cancer detection, COVID-19 severity assessment, and cardiac disease monitoring. Professor McDevitt’s innovative approach aims to enhance early detection capabilities, thereby improving patient outcomes and healthcare efficiency. 🌐

Award and Honor🏆

🏆 Professor John T. McDevitt has garnered prestigious awards and honors for his pioneering contributions to biomedical engineering and diagnostics. His groundbreaking work in developing ‘smart diagnostic‘ technologies has earned him recognition, including the 2016 AACC Wallace H. Coulter Lectureship Award and the Popular Science Best of What’s New Award in the Medical Device Category. He has also been honored with the Presidential Young Investigator Award and the Grace Fellowship, Stanford University. These accolades underscore his leadership in translating cutting-edge research into impactful clinical applications, further solidifying his reputation as a trailblazer in the field of bio-nanotechnology. 🌟

Research Skills🌟

🔬 Professor John T. McDevitt is renowned for his exceptional research skills in bio-nanotechnology and biomedical engineering. His expertise lies in developing advanced diagnostic technologies, including ‘smart diagnostic‘ devices and lab-on-a-chip systems. With over 219 peer-reviewed publications and more than 145 patents/patent applications to his name, he has made significant contributions to the field. Prof. McDevitt’s research focuses on integrating nanotechnology with clinical diagnostics, leveraging AI and mini-sensor ensembles for point-of-care testing. His innovative approach has revolutionized disease detection and monitoring, addressing critical healthcare challenges through interdisciplinary collaboration and cutting-edge scientific inquiry. 🌐

Achievements🏆

  • 🔬 Developed pioneering ‘smart diagnostic’ technologies.🏆 Received the 2016 AACC Wallace H. Coulter Lectureship Award.

    🌟 Honored with the Kathleen C. Kinnally Outstanding Scientific Achievement Award.

    🎖️ Recognized by Popular Science with the Best of What’s New Award in Medical Devices.

    🏅 Received the Presidential Young Investigator Award.

    📈 Elevated the field with over 219 peer-reviewed publications and 145 patents.

    💡 Founded multiple diagnostic companies, including OraLiva, advancing clinical diagnostics.

    💰 Raised over $47M in federal and foundation funding for research.

    🌐 Contributed to global health initiatives like HIV monitoring in Africa.

    🎓 Distinguished career spanning leadership roles at Rice University and NYU, shaping the future of bioengineering and biomaterials.

Projects💧🔬

  • 🔬 Point-of-Care Oncology Tool: Developed the first point-of-care oncology tool for precision medicine to monitor malignant transitions and recurrence in patients with oral epithelial dysplasia and prior oral cavity cancers.🧪 Lab-on-a-Chip System for Saliva-Based Diagnostics: Created a groundbreaking lab-on-a-chip system for saliva-based diagnostics aimed at cardiac disease, integrating 17 protein biomarkers for effective diagnosis.

    🦷 Monitoring Oral Cancer Patients: Led a project using novel lab-on-a-chip ensembles to monitor oral cancer patients, identifying cellular markers crucial for early detection and treatment.

    🔍 Texas Cancer Diagnostics Pipeline Consortium: Spearheaded multiple initiatives under this consortium focusing on oral, ovarian, and prostate cancers, employing advanced bio-nanochips to enhance diagnostic accuracy.

    🚔 Saliva-Based Drug Test at Point of Arrest: Designed bio-nanochips for saliva-based drug tests used at the point of arrest, aiding in the detection of drugs and metabolites efficiently.

Publications 📚

📚 Current developments in salivary diagnostics

  • Authors: CS Miller, JD Foley, AL Bailey, CL Campell, RL Humphries, …
  • Journal: Biomarkers in Medicine
  • Volume: 4
  • Issue: 1
  • Pages: 171-189
  • Citations: 509
  • Year: 2010

🔬 Aptamer-based sensor arrays for the detection and quantitation of proteins

  • Authors: R Kirby, EJ Cho, B Gehrke, T Bayer, YS Park, DP Neikirk, JT McDevitt, …
  • Journal: Analytical Chemistry
  • Volume: 76
  • Issue: 14
  • Pages: 4066-4075
  • Citations: 402
  • Year: 2004

🔍 Application of microchip assay system for the measurement of C-reactive protein in human saliva

  • Authors: N Christodoulides, S Mohanty, CS Miller, MC Langub, PN Floriano, …
  • Journal: Lab on a Chip
  • Volume: 5
  • Issue: 3
  • Pages: 261-269
  • Citations: 316
  • Year: 2005

👅 Solution-based analysis of multiple analytes by a sensor array: toward the development of an “electronic tongue”

  • Authors: JJ Lavigne, S Savoy, MB Clevenger, JE Ritchie, B McDoniel, SJ Yoo, …
  • Journal: Journal of the American Chemical Society
  • Volume: 120
  • Issue: 25
  • Pages: 6429-6430
  • Citations: 295
  • Year: 1998

🔬 Detection system based on an analyte reactive particle

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,602,702
  • Citations: 289
  • Year: 2003

🌟 Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels

  • Authors: JV Jokerst, A Raamanathan, N Christodoulides, PN Floriano, AA Pollard, …
  • Journal: Biosensors and Bioelectronics
  • Volume: 24
  • Issue: 12
  • Pages: 3622-3629
  • Citations: 283
  • Year: 2009

🩺 A microchip CD4 counting method for HIV monitoring in resource-poor settings

  • Authors: WR Rodriguez, N Christodoulides, PN Floriano, S Graham, S Mohanty, …
  • Journal: PLoS Medicine
  • Volume: 2
  • Issue: 7
  • Pages: e182
  • Citations: 272
  • Year: 2005

🔬 Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities

  • Authors: A Goodey, JJ Lavigne, SM Savoy, MD Rodriguez, T Curey, A Tsao, …
  • Journal: Journal of the American Chemical Society
  • Volume: 123
  • Issue: 11
  • Pages: 2559-2570
  • Citations: 260
  • Year: 2001

💡 Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study

  • Authors: PN Floriano, N Christodoulides, CS Miller, JL Ebersole, J Spertus, …
  • Journal: Clinical Chemistry
  • Volume: 55
  • Issue: 8
  • Pages: 1530-1538
  • Citations: 256
  • Year: 2009

🧬 Differential receptors create patterns diagnostic for ATP and GTP

  • Authors: SC McCleskey, MJ Griffin, SE Schneider, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 125
  • Issue: 5
  • Pages: 1114-1115
  • Citations: 245
  • Year: 2003

🔬 A microchip-based multianalyte assay system for the assessment of cardiac risk

  • Authors: N Christodoulides, M Tran, PN Floriano, M Rodriguez, A Goodey, M Ali, …
  • Journal: Analytical Chemistry
  • Volume: 74
  • Issue: 13
  • Pages: 3030-3036
  • Citations: 229
  • Year: 2002

🎨 Self-assembly of conjugated polymers at the air/water interface. Structure and properties of Langmuir and Langmuir− Blodgett films of amphiphilic regioregular polythiophenes

  • Authors: N Reitzel, DR Greve, K Kjaer, PB Howes, M Jayaraman, S Savoy, …
  • Journal: Journal of the American Chemical Society
  • Volume: 122
  • Issue: 24
  • Pages: 5788-5800
  • Citations: 223
  • Year: 2000

🛠️ Method and apparatus for the delivery of samples to a chemical sensor array

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,713,298
  • Citations: 212
  • Year: 2004

🔧 Systems and methods including self-contained cartridges with detection systems and fluid delivery systems

  • Authors: JT McDevitt, K Ballard, NJ Christodoulides, PN Floriano, GW Simmons
  • Publication: US Patent App. 11/993,705
  • Citations: 203
  • Year: 2010

🧪 Boronic acid based peptidic receptors for pattern-based saccharide sensing in neutral aqueous media, an application in real-life samples

  • Authors: NY Edwards, TW Sager, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 129
  • Issue: 44
  • Pages: 13575-13583
  • Citations: 203
  • Year: 2007